NasdaqCM:CPRXBiotechs
Does Catalyst Pharmaceuticals Rally Still Offer Value After 594% Five Year Surge?
Wondering if Catalyst Pharmaceuticals is still a smart buy after its huge multi year run, or if most of the upside is already priced in? This breakdown will help you consider whether the current share price offers real value or is primarily driven by momentum.
The stock has continued to grind higher, with gains of 0.5% over the last week, 2.0% over the last month, 10.3% year to date, 11.6% over the past year, and 594.2% over five years.
Recent market interest has been shaped by the company...